v3.26.1
Consolidated Balance Sheets (Unaudited) - USD ($)
Mar. 31, 2026
Dec. 31, 2025
CURRENT ASSETS:    
Cash $ 256,149 $ 238,245
Accounts receivable, net 9,195 0
Inventory, net 325,700 217,338
Prepaid expenses and other current assets 11,545 1,479
TOTAL CURRENT ASSETS 602,589 457,062
Property and equipment, net 0 0
Intangible assets, net 2,166,790 2,208,663
Other long term assets 0 0
Long term deposits 16,480 16,480
Operating lease right-of-use assets - net 0 0
Goodwill 467,409 467,409
Intercompany 0 0
TOTAL ASSETS 3,253,268 3,149,614
CURRENT LIABILITIES:    
Accounts payable and accrued expenses 5,746,706 5,410,261
Notes payable 2,333,815 2,336,554
Convertible debentures, net of discount 1,825,645 1,825,645
Operating lease liabilities - current 0 0
Deferred revenues 335,219 171,485
Factoring liability 822,968 843,068
Derivative liability 0 0
TOTAL CURRENT LIABILITIES 11,064,353 10,587,013
Notes payable - Long term 0 0
Operating lease liabilities - noncurrent 0 0
Other long term liabilities 0 0
TOTAL LIABILITIES 11,064,353 10,587,013
COMMITMENTS AND CONTINGENCIES (Note 10) 267,000 267,000
STOCKHOLDERS' EQUITY    
Common stock - $0.001 par value; 5,000,000,000 shares authorized; 1,649,816,690 and 425,980,711 shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively 1,649,817 425,981
Additional paid in capital 26,821,629 27,632,897
Accumulated other comprehensive loss 326,869 (139,757)
Accumulated deficit (36,130,637) (34,877,757)
Stemtech Corporation shareholders’ deficit (7,332,322) (6,958,636)
Non-controlling interest in subsidiaries (745,763) (745,763)
TOTAL STOCKHOLDERS EQUITY (8,078,085) (7,704,399)
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY $ 3,253,268 $ 3,149,614